Published in Vaccine Weekly, May 18th, 2005
According to a study from England, "The 1,1-bisphosphonate ester family member apomine (SR-45023A) is known to have anti-tumor activity in various cancer cell types. The aims of this study were to determine the effect of apomine on the growth of two breast cancer cell lines, MCF-7 and MDA-MB-231, to ascertain whether any growth inhibitory effects found were due to induction of apoptosis, and to investigate the mechanism of action of apomine. Apomine caused significant growth inhibition of both cell lines after 72 h of treatment."
"Apomine-induced growth inhibition was associated with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly